Header Logo

Connection

Raid Aljumaily to Cohort Studies

Back to Details
This is a "connection" page, showing publications Raid Aljumaily has written about Cohort Studies.
Raid Aljumaily
Connection Strength
0.038
Cohort Studies
  1. Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers. Clin Cancer Res. 2021 01 15; 27(2):447-459.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.